Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems
- 1 August 1986
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (8) , 1370-1373
- https://doi.org/10.1021/jm00158a008
Abstract
Note: In lieu of an abstract, this is the article's first page.This publication has 11 references indexed in Scilit:
- Mitoxantrone in advanced breast cancer—a phase II study with special attention to cardiotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- MYOCARDIAL EFFECTS OF MITOXANTRONE AND DOXORUBICIN IN THE MOUSE AND GUINEA-PIG1984
- Mitoxantrone: An active new agent in the treatment of advanced breast cancerCancer Chemotherapy and Pharmacology, 1984
- Comparison of cardiotoxicity of two anthracenediones and doxorubicin in ratsToxicology Letters, 1982
- CLINICAL AND CLINICAL PHARMACOLOGIC STUDIES OF MITOXANTRONE1982
- SAFETY ASSESSMENT OF A NEW ANTICANCER COMPOUND, MITOXANTRONE, IN BEAGLE DOGS - COMPARISON WITH DOXORUBICIN .2. HISTOLOGIC AND ULTRASTRUCTURAL PATHOLOGY1982
- SAFETY ASSESSMENT OF A NEW ANTICANCER COMPOUND, MITOXANTRONE, IN BEAGLE DOGS - COMPARISON WITH DOXORUBICIN .1. CLINICAL OBSERVATIONS1982
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- EXPERIMENTAL ANTI-TUMOR ACTIVITY OF AMINOANTHRAQUINONES1979
- ACTIVITY OF A NOVEL ANTHRACENEDIONE, 1,4-DIHYDROXY-5,8-BIS[[[2-[(2-HYDROXYETHYL)AMINO]ETHYL]AMINO]]-9,10-ANTHRACENEDIONE DIHYDROCHLORIDE, AGAINST EXPERIMENTAL-TUMORS IN MICE1979